HER2-Positive Breast Cancer: New Findings, Expanded Options, and an Evolving Treatment Paradigm

Learn from the experts how to leverage new and established HER2-targeting agents for optimal management of HER2+ early and metastatic breast cancer with these downloadable slides and on-demand Webcast.

Share

Program Content

Activities

HER2+ BC: Webcast
HER2-Positive Breast Cancer: New Findings, Expanded Options, and an Evolving Treatment Paradigm
Congratulations: You achieved a completion on 04/09/2022

Activities

<i>EP</i>: HER2+ EBC and MBC
ExpressPoints: An Evolving Treatment Paradigm in HER2-Positive Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 08, 2020

Expires: July 07, 2021

HER2+ EBC Guidance
Expert Guidance on the Evolving Therapeutic Landscape for HER2-Positive Early-Stage Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2020

Expires: June 29, 2021

HER2+ MBC Targeted Tx
HER2-Positive Metastatic Breast Cancer: Current Status and Promising Agents on the Horizon
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2020

Expires: June 29, 2021

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Puma Biotechnology, Inc.

Seagen